CALIBER THERAPEUTICS
Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. It offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices.
CALIBER THERAPEUTICS
Industry:
Delivery Health Care Therapeutics
Founded:
2005-01-01
Address:
New Hope, Pennsylvania, United States
Country:
United States
Website Url:
http://www.calibertherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(215)862-5797
Total Funding:
12 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Hubspot HubSpot CMS Hub Network Solutions DNS
Current Employees Featured
Founder
Investors List
SternAegis
SternAegis investment in Venture Round - Caliber Therapeutics
Official Site Inspections
http://www.calibertherapeutics.com
- Host name: 199.60.103.46
- IP address: 199.60.103.46
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Caliber Therapeutics"
Caliber Therapeutics 2025 Company Profile: Valuation, โฆ
Caliber Therapeutics General Information Description. Developer of proprietary drug-delivery products designed to provide treatment for artherosclerotic diseases. The company's products include targeted angioplasty drug and are โฆSee details»
Caliber Therapeutics, Inc.: Contact Details and Business Profile
The NAICS codes for Caliber Therapeutics, Inc. are [541, 54, 541714, 5417, 54171]. What is the SIC code for Caliber Therapeutics, Inc.? The SIC codes for Caliber Therapeutics, Inc. are โฆSee details»
Caliber Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Caliber Therapeutics, Inc. of New Hope, PA. Get the latest business insights from Dun & Bradstreet.See details»
Caliber Therapeutics, Inc. in New Hope, Pennsylvania - EIN TaxId
The Employer Identification Number (EIN) for Caliber Therapeutics, Inc. is 20-4508285. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Caliber โฆSee details»
Caliber Therapeutics - Company Profile - Tracxn
Feb 7, 2025 Caliber Therapeutics is focused development and commercialization of proprietary minimally-invasive, balloon-based drug delivery device for the intervention of vascular diseases. It offers targeted Angioplasty โฆSee details»
CALIBER THERAPEUTICS, INC. - CAGE.report
CALIBER THERAPEUTICS, INC. SEC: 0001710388. Caliber Therapeutics, Inc. Company Details. Identification, Location & Contacts This profile was last updated: 04/11/2012 ... Organization, โฆSee details»
Caliber Therapeutics - Crustdata Company Profile, Funding and โฆ
Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. โฆSee details»
Caliber Therapeutics - Company Info, Employees & Competitors
View Caliber therapeutics calibertherapeutics.com location in 150 un sq dr, new hope, pennsylvania, 18938, je, revenue, industry and description. Find related and similar companies โฆSee details»
Caliber Therapeutics, Inc.:Company Profile & Technical Research ...
Caliber Therapeutics, Inc. is headquartered in United States Pennsylvania. Caliber Therapeutics, Inc. was founded in 2005. Caliber Therapeutics, Inc. has a total of 6 patents . Related Topics. โฆSee details»
Caliber Therapeutics, Inc. - Employees, Contact info, Overview - Wiza
View info about Caliber Therapeutics, Inc. (calibertherapeutics.com). Caliber Therapeutics, Inc. is a company located in South Brunswick Township, New Jersey, United States. Find โฆSee details»
Caliber Therapeutics, Inc. Overview | SignalHire Company Profile
Caliber Therapeutics, Inc. is a private company. The company currently specializes in the Biotechnology area. The number of employees ranges from 1 to 25. The annual revenue of โฆSee details»
Caliber Therapeutics - Funding, Financials, Valuation & Investors
Caliber Therapeutics offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs. New. Resources. Advanced Search. ... How much funding โฆSee details»
Nextsource | Company Profile | Caliber Therapeutics
Explore the company profile of Caliber Therapeutics (calibertherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Caliber Therapeutics - Raised $13.4M Funding from 4 investors
Mar 9, 2025 Caliber Therapeutics's largest funding round was a Series B round held on Sep 29, 2017 for $12M. View all funding & investor details of Caliber Therapeutics. Our Lite Plan โฆSee details»
Caliber Therapeutics - Products, Competitors, Financials, โฆ
Caliber Therapeutics is a biomedical innovation company focused on developing transformative therapeutic products in the medical device sector. The company's main offerings include โฆSee details»
CALIBER THERAPEUTICS New Hope PA, 18938 - Company Profile
Free Business profile for CALIBER THERAPEUTICS at 150 Union Square Dr, New Hope, PA, 18938-1365, US. CALIBER THERAPEUTICS specializes in: Health and Allied Services, โฆSee details»
Caliber Therapeutics - Contacts, Employees, Board Members
Caliber Therapeutics offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs. ... Experience the new Crunchbase, powered by AI . โฆSee details»
Caliber Therapeutics, Inc. - Overview and Employees Official Email ...
Caliber Therapeutics, Inc. has a large market share in various products and services. As it is a Public Company Company so there are 1 - 50 employees working in Caliber Therapeutics, โฆSee details»
Caliber Therapeutics-ๅจ่็ฝ - vbdata.cn
Jan 1, 2005 Caliber Therapeutics่ดๅไบๅพฎๅ็ๅๅ่ฏ็ฉ้้ไบงๅ็ๅผๅๅๅไธๅ๏ผ็จไบๅนฒ้ขๅจ่็ฒฅๆ ท็กฌๅ็พ็ ใๅฎๆไพ้ถๅ่ก็ฎกๆๅฝขๆฏ่ฏ็ฉ่พ้็ๅ๏ผไธ็งๆๅ็ญ็ช่ฏ็ฉ็ๆ ๆฏๆถ่พ้ๅนณๅฐ๏ผ โฆSee details»
Tasman Therapeutics Advancing Oral Ketamine Program to Pivotal โฆ
1 day ago Tasman Therapeutics, Inc. (Tasman) has announced plans to raise $175 million in Series A funding to support the late-stage clinical development and eventual โฆSee details»